Why the MMJ Phytotech Ltd share price rocketed higher today

The MMJ Phytotech Ltd (ASX: MMJ) share price has been a big mover in morning trade following the release of a positive announcement.

At the time of writing the pot stock has climbed higher by 7.5% to 42 cents.

What happened?

This morning MMJ Phytotech announced that its Australian distribution partner HL Pharma has successfully imported its first shipment of medicinal products from its Swiss-subsidiary, Satipharm AG.

These products include two strengths of its Gelpell cannabidiol capsules to be used for a variety of medical conditions as approved by prescribing doctors under Australian Federal and State legislation.

As the Gelpell cannabidiol capsules are amongst the first medicinal cannabis products available to approved prescribers, management believes it further strengthens the company’s first-mover advantage.

Should you invest?

Whilst I agree that this does potentially give the company a slight first-mover advantage, I believe there is still a lot of work that needs to be done until doctors prescribe its Gelpell cannabidiol capsules.

So although the shipments have been imported, it might be a little too early to get overly excited. Especially with the likes of Auscann Group Holdings Ltd (ASX: AC8), Cann Group Ltd (ASX: CAN), and Zelda Therapeutics Ltd (ASX: ZLD) not far behind.

Because of this I would suggest investors hold off an investment for the time being and keep a close eye on the sector.

Until then I would suggest investors take a look at these explosive growth shares instead.

Top 3 ASX Blue Chips To Buy In 2017

For many, blue chip stocks means stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool's in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool's Top 3 Blue Chip Stocks for 2017."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

If you're expecting to see the likes of Commonwealth Bank, Telstra and Wesfarmers shares on this list, you'll be sorely disappointed. Not only are their dividends growing at a snail's pace, their profits are under pressure too due to the increasing competitive environment.

The contrast to these "new breed" blue chips couldn't be greater... especially the very real prospect of significant share price gains, something that's looking less likely from the usual blue chip suspects.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand - and how quickly the share prices of these companies moves - we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.